105 startups in Boston filed a Form D in the last 12 months. Together they reported $3.08B sold in 97 new rounds. The median round was $5.5M.
Startups
105
filed in 12 months
Reported new funding
$3.08B
97 rounds
Median round
$5.5M
new rounds
Largest rounds
Latest filings
| Company | Industry | Filed | Amount sold | Investors |
|---|---|---|---|---|
| Energy & Climate | Nov 12, 2026 | $3.5M ↗ | 7 | |
| Healthcare | Nov 12, 2026 | $100K ↗ | 2 | |
| Enterprise Software | Nov 10, 2026 | $15.3M ↗ | 10 | |
| Biotech & Pharma | Nov 4, 2026 | $5.4M ↗ | 7 | |
| Biotech & Pharma | Nov 4, 2026 | $2.0M ↗ | 13 | |
| Media, Entertainment & Gaming | Oct 30, 2026 | $150K ↗ | 1 | |
| Enterprise Software | Oct 22, 2026 | $4.9M ↗ | 3 | |
| Artificial Intelligence | Oct 22, 2026 | $97.3M ↗ | 18 | |
| Industrial & Robotics | Oct 21, 2026 | $2.4M ↗ | 3 | |
| FinTech & Financial Services | Oct 21, 2026 | $2.0M ↗ | 1 | |
| Biotech & Pharma | Oct 20, 2026 | $5.5M ↗ | 8 | |
| Healthcare | Oct 19, 2026 | $1.3M ↗ | 4 | |
| Healthcare | Oct 13, 2026 | $850K ↗ | 3 | |
| Artificial Intelligence | Oct 6, 2026 | $100K ↗ | 1 | |
| Biotech & Pharma | Sep 28, 2026 | $9.9M ↗ | 3 |
Boston companies 310
| Company | Industry | City | Latest filing | Latest raise |
|---|---|---|---|---|
 Afthonea IncInsurance brokerage for businesses with up to 500 employees. | FinTech & Financial Services | Boston | Jun 24, 2026 | $50K |
| Not classified yet | Boston | Jun 17, 2026 | $710K | |
 Memento Medicines, Inc.Develops antibody therapies for people with retinal diseases. | Biotech & Pharma | Boston | Jun 16, 2026 | $38.0M |
 Anodyne Nanotech, Inc.Develops skin patches to deliver medicines for people with chronic diseases. | Biotech & Pharma | Boston | Jun 11, 2026 | $12.5M |
 Creatio Inc.Software for businesses to automate workflows and manage customer relationships without coding. | Enterprise Software | Boston | Jun 11, 2026 | $9.5M |
 Carna Inc.Software helps healthcare systems detect and manage heart, kidney and metabolic conditions. | Healthcare | Boston | Jun 11, 2026 | $9.0M |
 S2N Health Inc.Sells market intelligence software and services to medical technology companies. | Enterprise Software | Boston | Jun 2, 2026 | $3.0M |
 Sloan Agricultural SocietyDeveloping a farmstay in Italy for travelers interested in food and agriculture. | Consumer & Retail | Boston | Jun 1, 2026 | $235K |
 Umajin Inc.Software for developers to build and publish applications across devices. | Enterprise Software | Boston | May 29, 2026 | $200K |
 Stone & Skillet Inc.Makes hand-griddled English muffins for consumers. | Food & Agriculture | Boston | May 20, 2026 | $4.0M |
| Biotech & Pharma | Boston | May 13, 2026 | $14.0M | |
 HavocAI Inc.Autonomy software and drone boats that let one operator run large military fleets. | Aerospace & Defense | Boston | May 12, 2026 | $187.4M |
| Not classified yet | Boston | May 11, 2026 | $105K | |
 Endlyz Therapeutics, Inc.Develops potential medicines for people with Parkinson’s disease and other dementias. | Biotech & Pharma | Boston | May 7, 2026 | $17.2M |
 JuliaHub, Inc.Cloud software for engineers and data scientists to develop programs and simulate physical systems. | Enterprise Software | Boston | May 4, 2026 | $46.6M |
 Nexamp, Inc.Develops solar projects and offers shared solar subscriptions to homes and businesses. | Energy & Climate | Boston | Apr 17, 2026 | $179.9M |
 Beacon Biosignals, Inc.Provides brain activity analysis and home sleep testing for drug developers and healthcare providers. | Healthcare | Boston | Apr 15, 2026 | $103.2M |
 Zydro Marine Technologies IncProvides maritime data tools for people and robots operating at sea. | Enterprise Software | Boston | Apr 14, 2026 | $1.9M |
| Not classified yet | Boston | Apr 13, 2026 | $50K | |
 Lumint CorpCurrency hedging services and software for institutional investors. | FinTech & Financial Services | Boston | Apr 9, 2026 | $500K |
 StataDx, Inc.Develops fingerstick blood tests for neurological disease assessment near patients. | Healthcare | Boston | Apr 7, 2026 | $1.8M |
 Porosome Therapeutics, Inc.Develops potential medicines targeting cell secretion defects in people with chronic diseases. | Biotech & Pharma | Boston | Mar 24, 2026 | $3.6M |
 Family First, Inc.Caregiving support benefits for employers and their employees. | Healthcare | Boston | Mar 24, 2026 | $950K |
 Strand Therapeutics Inc.Develops mRNA medicines for people with cancer and autoimmune diseases. | Biotech & Pharma | Boston | Mar 17, 2026 | $108.0M |
 Ankored, Inc.Software for youth sports organizations to manage background checks and safety requirements. | Enterprise Software | Boston | Mar 12, 2026 | $1.5M |
 Slate Medicines, Inc.Develops medicines to prevent migraines and other headache disorders. | Biotech & Pharma | Boston | Mar 11, 2026 | $9.9M |
 Solstice Oncology, Inc.Develops cancer immunotherapy for patients before surgery, beginning with colon cancer. | Biotech & Pharma | Boston | Mar 9, 2026 | $121.2M |
| Consumer & Retail | Boston | Mar 4, 2026 | $29K | |
 TetraScience, Inc.Scientific data management and AI software for life sciences companies. | Enterprise Software | Boston | Feb 27, 2026 | $14.9M |
 Marvix AI, Inc.AI medical documentation software for specialty care clinicians. | Healthcare | Boston | Feb 27, 2026 | $2.8M |
| Biotech & Pharma | Boston | Feb 23, 2026 | $25.0M | |
| Not classified yet | Boston | Feb 13, 2026 | $550K | |
| FinTech & Financial Services | Boston | Feb 13, 2026 | $50K | |
| Not classified yet | Boston | Feb 9, 2026 | $2.0M | |
| Not classified yet | Boston | Jan 27, 2026 | $11.3M | |
| Not classified yet | Boston | Jan 23, 2026 | $239.6M | |
| Not classified yet | Boston | Jan 20, 2026 | $11.3M | |
| Not classified yet | Boston | Jan 20, 2026 | $13.3M | |
| Not classified yet | Boston | Jan 16, 2026 | $7.0M | |
| Healthcare | Boston | Jan 12, 2026 | $4.5M | |
| Not classified yet | Boston | Jan 7, 2026 | $150.0M | |
| Not classified yet | Boston | Jan 2, 2026 | $19.9M | |
| Biotech & Pharma | Boston | Dec 31, 2025 | $700K | |
| Not classified yet | Boston | Dec 29, 2025 | $24.5M | |
| Biotech & Pharma | Boston | Dec 23, 2025 | $37.8M | |
| Healthcare | Boston | Dec 18, 2025 | $29.5M | |
| Biotech & Pharma | Boston | Dec 16, 2025 | $66.6M | |
| Not classified yet | Boston | Dec 8, 2025 | $13.3M | |
| Not classified yet | Boston | Dec 8, 2025 | $50K | |
| Biotech & Pharma | Boston | Dec 4, 2025 | $214.0M |
How this page is built
Startups are the private companies counted as startups (see our startup funding data), placed by the address on their latest Form D. Registered-agent and virtual-office addresses are not counted as a location. Public companies, foreign issuers and business-combination filings are excluded.